@fandremd : 2 years after dg of early BC; 21% of patients could not return to work. Trastuzumab (IV) is associated with a lower rate of return-to-work . A new report from CANTO study published in J Clin Oncol. Q: does trastuzumab SC increases return to work? #SABCS19 ascopubs.org/doi/abs/150.120… • TwiCopy

FabriceAndre

@fandremd

+ Follow

Head of Research Division of @GustaveRoussy , @myesmo President Elect

ID: 4061204056

calendar_today28-10-2015 14:23:49

3,3K Tweet

14,14K Followers

503 Following

FabriceAndre

@fandremd

6 years ago

2 years after dg of early BC; 21% of patients could not return to work. Trastuzumab (IV) is associated with a lower rate of return-to-work . A new report from CANTO study published in J Clin Oncol. Q: does trastuzumab SC increases return to work? #SABCS19 ascopubs.org/doi/abs/10.120…

thumb_up_off_alt75

chat_bubble_outline5

repeat29

shareShare